Parp inhibitor synthetic lethality in atm biallelic mutant cancer cell lines is associated with brca1/2 and rad51 downregulation

HIGHLIGHTS

• What: The analysis involved four steps: a global threshold was applied to the Hoechst image using a manual threshold of 0.04 (2,621.4/65535). The studies demonstrated that the homozygous loss of hATM in the DLD-1 cell line significantly increased the sensitivity of DLD1 cells to niraparib by 80-fold compared to the ATM-proficient parental DLD-1 cell line. While the study provides a compelling rationale for exploring PARP inhibitors as targeted therapy in ATM-deficient tumors, further investigation into the functional consequences of various ATM mutations is warranted. While the study provides . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.